Results 131 to 140 of about 1,300 (164)

Novel mouse model reveals neurodevelopmental origin of PMM2-CDG brain pathology

open access: yes
AbstractCongenital disorders of glycosylation (CDG) are a group of neurogenetic conditions resulting from disruptions in the cellular glycosylation machinery. The majority of CDG patients have compound heterozygous pathogenic variants in the phosphomannomutase 2 (PMM2)gene.
Andrew C. Edmondson   +19 more
openaire   +1 more source

Investigation of the Clinical and Genetic Spectrum of PMM2-CDG: Insights from a Family with a Novel Variant and Previous Studies. [PDF]

open access: yesArch Iran Med
Alagha P   +6 more
europepmc   +1 more source

Defeitos congénitos de glicosilação (cdg) em portugal: a ponta do iceberg [PDF]

open access: yes, 2014
Jaeken, J   +5 more
core  

Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG)

open access: yes
Stroke-like episodes (SLE) occur in phosphomannomutase deficiency (PMM2-CDG), and may complicate the course of channelopathies related to Familial Hemiplegic Migraine (FHM) caused by mutations in CACNA1A (encoding Ca2.1 channel). The underlying pathomechanisms are unknown.
Izquierdo-Serra, Mercè||   +19 more
openaire   +1 more source

Glycosylation defects in lipid metabolism [PDF]

open access: yes, 2020
van den Boogert, M.A.W.
core  

Clinical and genetic characterization of congenital disorders of glycosylation in 20 Chinese patients. [PDF]

open access: yesOrphanet J Rare Dis
Zhao P   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy